SYSTEM AND METHOD FOR MEDICAL IMAGING

Abstract

A system and for determining the presence or absence of myocardial ischemia in a subject, based upon analysis of medical images of at least one region of the heart of a subject of interest, the plurality of medical images being acquired in a consecutive manner by a medical imaging modality and being a plurality of myocardial layers in a direction which is generally perpendicular to the wall of the left ventricular myocardium.

Claims

1. A system for determining the presence or absence of myocardial ischemia in a subject of interest, by analyzing a plurality of medical images of at least one region of the heart of the subject of interest during a first-pass dose of a contrast agent, the plurality of medical images being acquired in a consecutive manner by a medical imaging modality, the system comprising (i) a delineation unit, configured to delineate contours of a selected region of the heart of the subject of interest in the plurality of medical images and to divide the selected region into a plurality of myocardial layers in a direction generally perpendicular to the wall of the left ventricular myocardium; and (ii) an intensity sampler and analyzing unit configured to sample signal intensities of myocardial image positions from the plurality of medical images, and, for each of the myocardial layers, analyse a sampled signal intensity in the selected region over time and compare the results with those obtained at a reference point in the left ventricle to determine a first index number indicative of a spatio-temporal perfusion inhomogeneity or perfusion dephasing among at least a subset of the myocardial layers in the said region as compared to a similar index number obtained in a normal heart; and where said first index number is greater than the similar index number, diagnosing the presence of ischemia.

2. The system of claim 1 wherein the medical imaging modality is selected from a magnetic resonance (MR), computer tomography (CT), or single photon emission computed tomography (SPECT) scanner

3. The system of claim 1 wherein the plurality of layers is from two to fifty layers.

4. The system of claim 1 which is arranged to analyse images from layers within a plurality of planes in various regions of the heart simultaneously.

5. The system of claim 1 which is arranged to analyse a further plurality of medical images acquired in a consecutive manner simultaneously with the plurality of medical images, in a further direction which is generally in the direction of blood flow through large epicardial coronary arteries running on the surface of the heart, wherein the delineation unit is further arranged to segment at least a selected part of the heart into a plurality of radial myocardial segments; and the intensity sampler and analyzing unit is further configured to sample and analyse the medical images obtained over time and comparing the results with those obtained at a reference point within the left ventricle to determine a second index number indicative of a spatio-temporal perfusion inhomogeneity or perfusion dephasing among at least a subset of radial myocardial segments of the plurality of myocardial segments in the further direction; and thereafter, as compared to a similar index number obtained in a normal or model heart; and where said second index number is greater, recording a positive result.

6. The system according to claim 5 wherein the second index number is used to distinguish MVD from CAD in a patient suffering from ischemia.

7. The system according to claim 5 wherein the second index number is compared with a similar index obtained using a model or phantom heart.

8. The system according to claim 1 which is configured to exclude known areas of scar tissue from the analysis.

9. The system according to claim 5 which is further configured to correlate the first index number and second index number, and where the first index number is negative or only slightly positive, and the second index number is positive to relate this to the existence of scar tissue in that area.

10. The system according to claim 9 which is configured to obtain a further set of medical images after a period of time and using those images to confirm the presence of scar tissue.

11. The system according to claim 10 wherein the period of time is from 3 to 5 minutes.

12. The system according to claim 10 which is configured to map scar tissue in three-dimensions across the heart.

13. The system of claim 1 which further includes means for conducting quantification of myocardial blood flow in each of the plurality of layers or segments

14. The system of claim 1 wherein the acquiring of the plurality of medical images of at least a portion of the heart of the subject of interest is at least partially synchronized to a cyclic movement of the heart of the subject of interest.

15. A method for determining or confirming the presence or absence of ischemia in a patient, said method comprising obtaining medical images of at least a portion of the heart of the subject using imaging modality such as an MR, CT or SPECT scanner, determining a first index number as defined in claim 1, and using the results to diagnose the presence or absence of ischemia.

16. A method according to claim 15 which further comprises obtaining medical images suitable for providing a second index number, and using the results to distinguish between CAD or MVD in an ischemic patient, or to delineate scar tissue in the heart.

17. A storage medium or distribution platform storing a software application comprising the system of claim 1.

18. A storage medium or distribution platform storing a software application arranged to determine a first index number as defined in claim 1.

19. A storage medium or distribution platform according to claim 18, further arranged to determine a second index number.

Description

DETAILED DESCRIPTION OF THE INVENTION

[0069] The invention will now be particularly described by way of example with reference to the accompanying diagrammatic drawings in which:

[0070] FIG. 1 shows schematically (1A) an epicardium of a heart; (1B) is a schematic of the peak pattern are obtained from first pass analysis in this direction in the epicardial layer, the endocardial layer and the signal vs time at the reference point in the left ventricle in a normal heart; and (1C) is a schematic of the peak pattern are obtained from first pass analysis in this direction in the epicardial layer, the endocardial layer and the signal vs time at the reference point in the left ventricle in an ischemic heart;

[0071] FIG. 2 shows schematically (2A) radial heart segments, and FIGS. 2B) and (2C) show a schematic of peak patterns that may be obtained from first pass analysis in this direction in the radial direction.

EXAMPLE 1

[0072] Detection of Ischemia Using System of the Invention

[0073] FIG. 1A illustrates schematically an epicardium of the heart, which has been divided into an epicaridal layer (1) and an endocardial layer (2) around a central blood vessel. First-pass CT, MR or SPECT images are taken in this direction and signals from the individual layers (1, 2) are determined using the system of the invention. This generates a number of peaks as illustrated in FIGS. 1B and 1C. In these graphs, the signal intensity vs time at the reference point in the left ventricle is shown as the light grey peak (3). The signal intensity versus time peak in the epicardial layer (1) is shown as a solid black line and the signal intensity versus time peak in the endocardial layer (2) is shown as a dashed line. Although peak signal intensity may be expected to vary over time in each of these layers as compared to the reference point, the time to peak intensity TTPI (shown by an X in FIGS. 1B and 1C), may be expected to be similar or vary over only a small range in a normal heart, as illustrated in FIG. 1B.

[0074] In a case of ischemia, there will be an inhibition of the flow of blood through the myocardium, giving rise to a more significant difference or spread between the TTPIs between the various layers and the reference point, as illustrated in FIG. 1C. Thus, the TTPI index in this case will be positive, indicative of ischemia in a patient.

EXAMPLE 2

[0075] Determination of the Presence of Scar Tissue and Distinction Between CAD and MVD

[0076] In accordance with a further aspect of the invention, the system is arranged to obtain a further index, based upon measurements taken from a plurality of radial myocardial segments (4,5,6 and 7) in a similar plane to those of the layers used in Example 1 as illustrated in FIG. 2A. In this case, the TTPI index, defined as the difference between the time to peak intensity at the reference point as shown by grey line (8) as compared to the time to peak intensity in all individual radial segments is relatively low in FIG. 2B, with the TTPIs for each of the individual radial segments 4,5,6 and 7, being broadly similar. Where this result follows a positive identification of ischemia as a result of the analysis of Example 1, this provides an indicator that the individual may be suffering from MVD. Alternatively, where the results from Example 1 are negative, this result would confirm that the heart is normal.

[0077] A different result showing a relatively high TTPI is shown in FIG. 2C, with the TTPI of segment 5 being longer than that for segments 4, 6 and 7. Where this result follows a positive diagnosis of ischemia from Example 1, this would suggest that the patient has CAD, which is impeding blood flow in the vessels around segment 5.

[0078] However, where this result follows a negative result in Example 1, this suggests that there is scar tissue present in the relevant segment 5, which is causing an abnormal flow rate.

[0079] The presence of scar tissue may also be implied in cases where there is only a very slight increase of measured dyssynchrony values in both the radial and transmural directions as compared to the normal heart. Confirmation of the presence of scar tissue may be made by re-sampling of the data in the sample myocardial segments and layers after a period of time, for example after 5 minutes, if necessary in conjunction with late gadolinium (hyper)-enhancement images. In scar tissue, gadolinium would not have cleared the region after that period and so a positive signal would still be present. Once the presence of scar tissue has been identified, these regions may be excluded from future analysis to avoid false negative results in the case of ischemia, and/or false positives for CAD.

[0080] If these measurements from Examples 1 and 2 are gathered in a plurality of planes across the myocardium, scar tissue may be effectively mapped in three dimensions.

[0081] Once identified, the system may be programmed to exclude results from areas of scar tissue in future analysis.